Medical cannabis, HSA/FSA, patient rights, state programs and reimbursement guidance.
Most state programs use physician certifications or recommendations rather than a conventional prescription dispensed by a pharmacy. The distinction matters for federal law, benefit plans, travel and employment.
Read article →Some states recognize visiting patients, some require temporary registration and others offer no reciprocity. Never transport cannabis across state lines based solely on reciprocity assumptions.
Read article →Reciprocity varies sharply. Some states recognize visiting patients, some require temporary registration, and others provide no purchasing rights to out-of-state cardholders. Possession rules, product limits, and transportation laws…
Read article →Most state programs rely on physician certifications or recommendations rather than a conventional federal prescription filled by a pharmacy. This distinction matters when discussing controlled-substance law, HSA/FSA eligibility,…
Read article →Patients should watch for a final federal rule, its effective date, IRS and Treasury guidance, FDA implications and changes to HSA/FSA administrator policies. State legality and federal treatment…
Read article →Medical cannabis may be authorized by a state, but HSA eligibility is determined under federal qualified-medical-expense rules and the account administrator’s procedures. Patients should not assume a medical…
Read article →Use the official state regulator’s license lookup, match the legal business name and address, confirm active status, and check whether the location is licensed for medical or adult-use…
Read article →Use the official state regulator’s license search rather than relying only on maps, advertisements, or review sites. Match the business name and address, check license status and expiration,…
Read article →Eligibility of an expense and the threshold for claiming an itemized medical deduction are separate questions. Taxpayers should use current IRS instructions and professional advice.
Read article →Rescheduling could affect research, business taxation, prescribing pathways, and public policy, but it would not automatically convert every state dispensary product into an FDA-approved prescription drug or every…
Read article →